IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology

STAT+: Prime wins Beam arbitration, clearing path to clinic

UAB receives $4 million from Novo Nordisk to expand Live HealthSmart Alabama health initiative

The University of Alabama at Birmingham (UAB) received a $4 million investment from pharmaceutical company Novo Nordisk to expand its Live H

Keenova eyes Xiaflex as first drug for plantar fibromatosis

GSK ends dementia alliance with Alector after setbacks

NICE aims to cut funding for Amgen lung cancer drug Lumykras

Is pure play pharma's new pharmakon?